Melanie Ivarsson OBE in

Melanie Ivarsson OBE

Login to view DISC.
Founder and CEO at Ridgelight Consulting Ltd
📍 United Kingdom

Dr. Melanie Ivarsson is a biotech executive with over 25 years of experience in the life sciences industry, holding leadership roles at Moderna, Pfizer, and Takeda. She holds a PhD from the University of Bristol and an MBA from MIT Sloan, and she specializes in global clinical development and strategic operational projects.

Her professional passions include driving innovation in healthcare, particularly through cross-functional collaboration and new technologies. She frequently speaks on panels about the future of the life sciences sector and has a keen interest in accelerating drug development for rare diseases and improving public health through large-scale clinical programs.

She was awarded an OBE (Officer of the Order of the British Empire) in the 2022 New Years Honours List for her services to public health, particularly for leading the clinical trials for one of the first Covid-19 vaccines at Moderna.

Read the full overview →
Experience
5 Years
Current Role
Founder and CEO
Job Level
Leadership
Location
United Kingdom
Personality Overview

How Melanie shows up

Communication Style
Decision Approach
Work Preference

Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.

Login to view personality overview.
Priorities

Topics Melanie cares about

AI in Drug Development
Serves on the advisory board for PhaseV, an AI-driven clinical trial company, and frequently discusses how AI can accelerate drug development and redefine how trials are executed.
Rare Disease Therapies
Has a background in developing treatments for rare conditions like Huntington's Disease and lysosomal storage disorders, and continues to express excitement for advancing research in these areas.
+5 more topics Login to view topics
Career

Work history

8-2025
Founder and CEO
Ridgelight Consulting Ltd
9-2025
Board Member
Protas
7-2025
Scientific Advisory Board member
PhaseV
1-2022
Non Executive Director
LoQus23 Therapeutics Ltd
11-2024 - 6-2025
Advisor
Moderna
In the press

Media appearances

No media yetWe could not find public media appearances for this person.
Education
2017 - 2019
Master of Business Administration - MBA
MIT Sloan School of Management
PhD
University of Bristol
Social presence
in
Behavioral profile

DISC profile (public)

DISC behavioral profile

Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.

Login to view DISC.

More profiles

Discover additional public profiles from our index.

Unlock the full playbookSee exactly how to sell to Melanie. Free, 10 seconds.